Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1975 1
1977 1
1979 1
1982 1
1983 1
1984 4
1985 1
1986 1
1988 1
1989 1
1993 1
1994 3
1995 5
1996 3
1997 1
1998 1
1999 4
2000 4
2001 2
2002 8
2003 1
2004 8
2005 2
2006 3
2007 5
2008 2
2009 1
2010 3
2011 9
2012 8
2013 4
2014 13
2015 8
2016 7
2017 10
2018 4
2019 6
2020 12
2021 3
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Ovarian dysgenesis 6"
Page 1
Swyer syndrome.
King TF, Conway GS. King TF, et al. Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):504-10. doi: 10.1097/MED.0000000000000113. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 25314337 Review.
In 46,XY gonadal dysgenesis, lack of testis development may be triggered by sex determining region Y, NR5A1, DHH or testis-determining gene loss-of-function mutations, DAX1 or WNT4 duplication or MAP3K1 gain-of-function mutations. ...Pregnancy is possible via ova donation, …
In 46,XY gonadal dysgenesis, lack of testis development may be triggered by sex determining region Y, NR5A1, DHH or testis-determinin …
Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
Bužinskienė D, Marčiukaitytė R, Šidlovska E, Rudaitis V. Bužinskienė D, et al. Medicina (Kaunas). 2023 Jun 6;59(6):1097. doi: 10.3390/medicina59061097. Medicina (Kaunas). 2023. PMID: 37374301 Free PMC article. Review.
Ovarian Leydig cell tumor is a rare type of ovarian steroid cell neoplasms, presenting in only 0.1% of all ovarian tumor cases, and is generally androgen-secreting and unilateral. Although they are often malignant non-spreading tumors, which have excellent
Ovarian Leydig cell tumor is a rare type of ovarian steroid cell neoplasms, presenting in only 0.1% of all ovarian tumo
PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M, Luque-Ramírez M, Nattero-Chávez L, Escobar-Morreale HF. Millán-de-Meer M, et al. Hum Reprod Update. 2023 Nov 2;29(6):741-772. doi: 10.1093/humupd/dmad015. Hum Reprod Update. 2023. PMID: 37353908
OBJECTIVE AND RATIONALE: We performed a systematic review and meta-analysis of data on the pathophysiology, clinical manifestations, diagnosis, prognosis, and treatment of women 45 years of age-peri- or postmenopausal-with PCOS. ...Sensitivity analyses restricted the meta- …
OBJECTIVE AND RATIONALE: We performed a systematic review and meta-analysis of data on the pathophysiology, clinical manifestations, diagnos …
Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients.
Garzia E, Galiano V, Marfia G, Navone S, Grossi E, Marconi AM. Garzia E, et al. Reprod Biol Endocrinol. 2022 Jan 4;20(1):6. doi: 10.1186/s12958-021-00876-0. Reprod Biol Endocrinol. 2022. PMID: 34983571 Free PMC article. Clinical Trial.
In addition, lower serum testosterone levels at baseline were found to be the major predictor of treatment discontinuation. CONCLUSIONS: In women with PCOS, menstrual pattern imbalance and ovarian androgens excess are the best predictors of metformin response …
In addition, lower serum testosterone levels at baseline were found to be the major predictor of treatment discontinuation. CONCLUSIO …
Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Schein PS, Winokur SH. Schein PS, et al. Ann Intern Med. 1975 Jan;82(1):84-95. doi: 10.7326/0003-4819-82-1-84. Ann Intern Med. 1975. PMID: 67817 Review.
These drugs have specific toxic effects on fertility in both males, through its disruption of the testicular function, and in females, for ovarian disruptions. Antifolics, 6-mercaptopurine, azathioprine, and alkylating agents, used for therapy in pregnant women, particular …
These drugs have specific toxic effects on fertility in both males, through its disruption of the testicular function, and in females, for …
Pelvic masses after surgery for immature ovarian teratoma: A 10-year experience of Western China.
Xie S, Jia X, Li T, Xu Y, Wu W, Qiu Y, Yuan S, Peng X, Wang H. Xie S, et al. Medicine (Baltimore). 2022 Aug 5;101(31):e29727. doi: 10.1097/MD.0000000000029727. Medicine (Baltimore). 2022. PMID: 35945757 Free PMC article.
There are debates on the management of immature ovarian teratoma and its recurrence. This study aimed to report the incidence of pelvic masses after surgery for immature ovarian teratoma and to identify prognostic factors of disease-free survival after surger …
There are debates on the management of immature ovarian teratoma and its recurrence. This study aimed to report the incidence of pelv …
Are ovarian response and pregnancy rates similar in selected FMR1 premutated and mutated patients undergoing preimplantation genetic testing?
Ranisavljevic N, Hess M, Castelli C, Willems M, Ferrieres-Hoa A, Girardet A, Anahory T. Ranisavljevic N, et al. J Assist Reprod Genet. 2020 Jul;37(7):1675-1683. doi: 10.1007/s10815-020-01809-3. Epub 2020 Jun 2. J Assist Reprod Genet. 2020. PMID: 32483686 Free PMC article.
PURPOSE: To assess if the ovarian response of FMR1 premutated women undergoing preimplantation genetic testing (PGT) for Fragile X syndrome is lower compared with fully mutated patients, due to their frequent premature ovarian failure. ...Neither the number of CGG r …
PURPOSE: To assess if the ovarian response of FMR1 premutated women undergoing preimplantation genetic testing (PGT) for Fragile X sy …
The lucky and the unlucky.
Geirsson RT. Geirsson RT. Acta Obstet Gynecol Scand. 2011 Jun;90(6):557-8. doi: 10.1111/j.1600-0412.2011.01154.x. Acta Obstet Gynecol Scand. 2011. PMID: 21592107 Free article. No abstract available.
New STAG3 gene variant as a cause of premature ovarian insufficiency.
Gómez-Rojas S, Aristizábal-Duque JE, Muñoz-Fernández LF, Sarmiento-Ramón MP, Pereira-Gómez MDP. Gómez-Rojas S, et al. Rev Colomb Obstet Ginecol. 2022 Mar 30;73(1):142-148. doi: 10.18597/rcog.3806. Rev Colomb Obstet Ginecol. 2022. PMID: 35503298 Free PMC article. English, Spanish.
A homozygous pathogenic variant not previously reported in the STAG3 gene, which has been associated with premature ovarian insufficiency (POI), was identified. Conclusions: In this case, clinical exome sequencing was key for identifying a STAG gene abnormality, probably a …
A homozygous pathogenic variant not previously reported in the STAG3 gene, which has been associated with premature ovarian insuffici …
The clinical features and reproductive prognosis of ovarian neoplasms with hyperandrogenemia: a retrospective analysis of 33 cases.
Shu S, Deng S, Tian JQ, Chen R, Sun JA, Yu Q, Zhu Liu F, Huang LR, Pan YL, Yang XJ, Fan BQ, Liu YH. Shu S, et al. Gynecol Endocrinol. 2019 Sep;35(9):825-828. doi: 10.1080/09513590.2019.1599855. Epub 2019 Apr 16. Gynecol Endocrinol. 2019. PMID: 30990090
The aim of this study is to review the natural course, clinical features, and reproductive prognosis of ovarian tumors associated with hyperandrogenemia. We retrospect 33 patients of ovarian tumors with hyperandrogenemia. Thirty cases (91%) were sex co …
The aim of this study is to review the natural course, clinical features, and reproductive prognosis of ovarian tumors …
158 results